Boston Scientific ($BSX) is plowing ahead with major growth plans in China, despite regulatory, bureaucratic and competitive obstacles. The Massachusetts medical device giant has set its sights on new acquisitions there and will also launch more doctor-education centers across China, The Wall Street Journal reported. Warren Wang, vice president and managing director of the company's China division, told the newspaper executives want to achieve 30% annual sales increases in China over the next 5 years through these and other initiatives. The idea is to counter stagnant sales in the U.S. and Europe, where Boston Scientific continues to reorganize and seek new M&A opportunities in an ongoing fight to renew robust sales and revenue growth. Story